Compounds > atractylenolide iii
Page last updated: 2024-09-04

atractylenolide iii and Fibrosis

atractylenolide iii has been researched along with Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, S; Kang, H; Tan, S; Wang, H; Yang, S; Zhang, Y; Zhou, K1
Chen, N; Ke, C; Liu, Y; Shi, K; Tu, J; Wang, B; Wang, Y; Zhou, Z1

Other Studies

2 other study(ies) available for atractylenolide iii and Fibrosis

ArticleYear
Atractylenolide III Ameliorated Autophagy Dysfunction via Epidermal Growth Factor Receptor-Mammalian Target of Rapamycin Signals and Alleviated Silicosis Fibrosis in Mice.
    Laboratory investigation; a journal of technical methods and pathology, 2023, Volume: 103, Issue:2

    Topics: Animals; Autophagy; ErbB Receptors; Fibrosis; Humans; Mice; Silicosis; Sirolimus; TOR Serine-Threonine Kinases

2023
Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism.
    Molecules (Basel, Switzerland), 2023, Jul-19, Volume: 28, Issue:14

    Topics: Animals; Bile Ducts; Fibrosis; Glutamine; Liver; Liver Cirrhosis; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt

2023